Ginkgo Bioworks Holdings, Inc.DNANYSE
Loading
EBITDA Over TimeExpanding
Percentile Rank67
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-254.61M
↑ 68% vs avg
Percentile
P67
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-805.98M
Historical baseline
PeriodValueYoY Change
2025$-254.61M+47.4%
2024$-484.39M+41.0%
2023$-821.29M+60.1%
2022$-2.06B-14.0%
2021$-1.81B-1563.8%
2020$-108.58M-1.8%
2019$-106.66M-